Evidence Hub

Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis

Xiao-Hui Fang, Yu-Hang Yin, Qin-Ke Wu, Lucy Chai, Yifan Guo, Zhen-Hua Tong, N. Méndez-Sánchez, Xing-Shun Qi

Expert Review of Clinical Pharmacology, 2025

993 participants · 3 citations

Abstract

ABSTRACT Introduction Nonalcoholic fatty liver diseases (NAFLD) and metabolic dysfunction-associated fatty liver diseases (MAFLD) are closely associated with metabolic syndrome, including obesity, dyslipidemia, and insulin resistance (IR). Thus, stains may be considered for the management of NAFLD/MAFLD. However, its efficacy and safety remain unclear in NAFLD/MAFLD. Methods The PubMed, EMBASE, and Cochrane library databases were searched to identify randomized controlled trials (RCTs) evaluating the efficacy and/or safety of statins in NAFLD/MAFLD. Risk ratios (RRs) and weight mean differences (WMDs) with their 95% confidence intervals (CIs) were calculated. Results Seven studies involving 993 patients with NAFLD/MAFLD were included. Statins were significantly associated with reductions in alanine aminotransferase (ALT, WMD = −9.76 U/L, 95%CI: −17.28, −2.24, p = 0.010), aspartate aminotransferase (AST, WMD = −4.46 U/L, 95%CI: −9.03, 0.11, p = 0.060), gamma-glutamyl-transpeptidase (GGT, WMD = −10.18 U/L, 95%CI: −13.65, −6.70, p < 0.001), low-density lipoprotein (LDL, WMD = −0.86 mmol/L, 95%CI: −1.06, −0.66, p < 0.001), total cholesterol (TC, WMD = −0.88 mmol/L, 95%CI: −1.14, −0.61, p < 0.001), and triglyceride (TG, WMD = −0.32 mmol/L, 95%CI: −0.45, −0.19, p < 0.001) levels. Additionally, statins did not increase the risk of myalgia (RR = 0.96, 95%CI: 0.10, 9.00, p = 0.970). Conclusions Statins could improve liver function and lipid profiles in NAFLD/MAFLD. No myalgia was…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 993 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free